Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06751290
PHASE4

The Use of Cyproheptadine in Pediatric Feeding Disorders

Sponsor: University of Miami

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if Cyproheptadine, an appetite stimulant, can improve eating habits in children with Pediatric Feeding Disorders. Pediatric Feeding Disorders is a broad term that describes disorders of eating-related behaviors that causes altered consumption of food and impairs physical or psychosocial health.

Official title: The Use of Cyproheptadine to Improve Eating Habits in Children With Pediatric Feeding Disorders

Key Details

Gender

All

Age Range

2 Years - 6 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-12-30

Completion Date

2026-04-30

Last Updated

2026-03-05

Healthy Volunteers

No

Interventions

DRUG

Cyproheptadine

Initiation of Cyproheptadine at 0.25mg/kg once daily by mouth at bedtime and titration up to at most three times daily as per participant's primary gastroenterologist.

BEHAVIORAL

Nutritional Counseling

This includes in person counseling by a provider once in office for up to 15 minutes as well as standardized hand out with basic nutritional guidance on high-calorie foods.

BEHAVIORAL

Behavioral Counseling

This includes in person counseling by a provider once in office for up to 15 minutes as well as standardized hand out with basic behavioral guidance.

Locations (1)

University of Miami Department of Pediatric Gastroenterology

Miami, Florida, United States